Article

PCa progression outcomes vary by surgeon experience

San Francisco--Surgeon experience is an independent predictor of PSA progression in men undergoing radical prostatectomy, but among high-volume surgeons (those who performed more than 100 procedures) operating in a single institution, the individual surgeon alone is also a significant prognostic factor, according to a study by researchers at Memorial Sloan-Kettering Cancer Center, New York.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
1 expert is featured in this series.
1 expert is featured in this series.
3 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
Related Content
Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
June 17th 2025

Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer

Hannah Clarke
ArteraAI is a multimodal artificial intelligence biomarker test that can predict therapy benefit and prognosticate long-term outcomes in prostate cancer.
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD
Ultrasound imaging system now available to guide nonsurgical urology procedures
June 16th 2025

Ultrasound imaging system now available to guide nonsurgical urology procedures

Hannah Clarke
The bkActiv S series is designed to guide nonsurgical urologic, colorectal, and pelvic floor procedures.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance
June 16th 2025

From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance

Anne K. Schuckman, MD Hannah Clarke
Anne K. Schuckman, MD, describes the growing number of options in NMIBC and the impact of these therapies on clinical practice.
Human Urinary System Kidneys with Bladder Anatomy | Image Credit: © magicmine - stock.adobe.com
June 13th 2025

CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC

Hannah Clarke
The CHAI biomarker was shown to outperform EAU and AUA stratifications.
© 2025 MJH Life Sciences

All rights reserved.